| # | Drug | Count |
|---|---|---|
| 0 | DOCETAXEL | 24 |
| 1 | DOCETAXEL ANHYDROUS | 24 |
| 2 | PREDNISONE | 24 |
| 3 | MYCOPHENOLATE MOFETIL | 22 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 22 |
| 5 | TRASTUZUMAB | 20 |
| 6 | CYCLOPHOSPHAMIDE | 13 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 13 |
| 9 | ACETAMINOPHEN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RILUZOLE | 1 | 0.0004 |
| 1 | ARSENIC TRIOXIDE | 1 | 0.0004 |
| 2 | DOCETAXEL ANHYDROUS | 24 | 0.0004 |
| 3 | DOCETAXEL | 24 | 0.0004 |
| 4 | TRASTUZUMAB | 20 | 0.0003 |
| 5 | GEMTUZUMAB OZOGAMICIN | 1 | 0.0003 |
| 6 | MYCOPHENOLATE MOFETIL | 22 | 0.0002 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 22 | 0.0002 |
| 8 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 1 | 0.0001 |
| 9 | SIROLIMUS | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 24 |
| 1 | Microtubule Inhibitor [EPC] | 24 |
| 2 | HER2/neu Receptor Antagonist [EPC] | 20 |
| 3 | Alkylating Drug [EPC] | 13 |
| 4 | Kinase Inhibitor [EPC] | 2 |
| 5 | mTOR Inhibitor Immunosuppressant [EPC] | 2 |
| 6 | 5-alpha Reductase Inhibitor [EPC] | 1 |
| 7 | Amide Local Anesthetic [EPC] | 1 |
| 8 | Antiarrhythmic [EPC] | 1 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Benzothiazole [EPC] | 1 | 0.0004 |
| 2 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 20 | 0.0003 |
| 4 | Microtubule Inhibitor [EPC] | 24 | 0.0001 |
| 5 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 13 | 0.0001 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 8 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 9 | Corticosteroid [EPC] | 24 | 0.0000 |